Strategic Development Rarecells Inc., a leading Liquid Biopsy company, announces the development of a revolutionary and accurately targeted digital single-cell Next-Generation Sequencing (scNGS) for single-nucleotide variant (SNV) method to detect… Continue reading Rarecell Developed An Approach For Tumor Cell Characterization
Strategic Development Exscientia Ltd., a leading AI-driven Pharmatech firm, announced that the world’s first AI-designed immuno-oncology molecule had entered human clinical trials. Exscientia and Evotec collaborated to co-invent and develop… Continue reading Exscientia: Clinical Trials for AI-Designed Immuno-Oncology Drug
In the industry news, we showcase our analytical viewpoint on development in the market, aligning with a company’s future growth initiatives. It entails a holistic impact across the organization, its… Continue reading COVID-19 Update: Global Vaccination Opportunity Missed
Picture Credit: Corinne Sandone, Johns Hopkins Medicine Strategic Development In a series of experiments that began with amoebas — single-celled species with podlike appendages that help them move around — Johns… Continue reading Amoeba Biology: Promising Lung Disease Treatment Target
In the industry news, IeB showcases its analytical viewpoint on transformative cloud-based technology, which aligns with a company’s future growth initiatives. It entails a holistic impact across the organization, its… Continue reading AI-Based Computational Pathology
Clinical Development Australia’s Noxopharm in-licensed RNA technology from Hudson Institute of Medical Research for the company’s subsidiary Pharmorage. Following the pre-clinical finding that Idronoxil (IDX), the active component of Veyonda®,… Continue reading Noxopharm in-licenses novel RNA tech for drug discovery, vaccines
Research Overview Researchers at Oregon State University’s Faculty of Pharmaceutical Sciences suggest that vaccines that stimulate the production of proteins essential to the skin’s antioxidant network may help patients strengthen… Continue reading mRNA Vaccines can Treat Skin Cancer
According to the Ingenious e-Brain market study for Internet of Medical Things market is expected to grow at a CAGR of 23% from 2021 to 2030. The Internet of Medical… Continue reading Internet of Medical Things
News Source:- >> | Image Source:- >> In a collaboration, Carl Zeiss Meditec and Precise Bio formed cooperation to create and market artificial corneal tissue for use in patients who require endothelial keratoplasty… Continue reading Carl Zeiss Meditec, Precise Bio: Ophthalmology Implant Collaboration
News Source:- >> | Image Source:- >> Taiwanese firm CancerFree Biotech Ltd. has developed a breakthrough for patients with stage 2 solid tumors. Stage 2 patients or above shorten the drug therapy selection… Continue reading CancerFree Biotech: First Personalized Cancer Cell System
